Increasing CIN by targeting mitotic regulators, including MPS1, a mitotic kinase involved in spindle assembly checkpoint (SAC) [52–55], has emerged as a valid approach to potently and preferentially kill cancer cells [56–63]. Here, TTK is linked to cancer.